comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Austell pharmaceuticals - Page 1 : comparemela.com
R101 million rights offer in the works for Ascendis
Ascendis says it will issue 143 million shares at an undiscounted 71 cents per share.
Harry-smit
Scientific-group
Austell-pharmaceuticals
Calibre-investment-holdings
Amka-products
Calibre-investment
Surgical-innovations
Ascendis inks R410m agreement to dispose of pharmaceuticals division to Austell
Ascendis entereed into a R590 million loan agreement with Austell Pharmaceuticals in May
Austell-pharmaceuticals
Ascendis-health
Solal owner reconstitutes its board
Since its listing in 2013, Ascendis’ share price has seen a significant drop of more than 93%.
Harry-smit
Bharti-harie
Carl-neethling
Lawrence-mulaudzi
Gary-shayne
Karsten-wellner
Amaresh-chetty
Austell-pharmaceuticals
Ascendis-health
Solal owner inks deal with new lender, avoids immediate payment of R550 million loan
Ascendis cut down its whopping debt that stood at R6.7 billion in 2021 by selling some of its assets, bringing it down to R582 million by December.
South-africa
South-african
Harry-smit
Bharti-harie
Carl-neethling
Ascendis-pharma
Amaresh-chetty
Pharmaq-holdings
Austell-pharmaceuticals
Ascendis-health
Capex-management
Ascendis-medical
South African Pharmaceutical Market 2022: Pandemic Continues to Cause Business Interruptions and Supply Chain Challenges
/PRNewswire/ The "Pharmaceutical Industry in South Africa 2022" report has been added to ResearchAndMarkets.com s offering. The importance of the.
South-africa
California
United-states
Dublin
Ireland
Nkunzi
Kwazulu-natal
South-african
Adcock-ingram
Alpha-pharm
Astellas-pharma
Afrigen-biologics
vimarsana © 2020. All Rights Reserved.